Syntaxin Binding Protein 1 Related Epilepsies

Abstract

Syntaxin binding protein 1 (STXBP1), commonly known as MUNC18–1, is a member of SEC1 family membrane trafficking proteins; their function consists in controlling the soluble N-ethylmaleimide-sensitive factor attachment protein receptors complex assembly, making them essentials regulators of vesicle fusion. The precise function and molecular mechanism through which Munc18–1 contributes to neurotransmitter releasing is not entirely understood, but several evidences suggest its probable role in exocytosis. In 2008, heterozygous de novo mutations in neuronal protein Munc18–1 were first referred as a cause of Ohtahara syndrome development. Currently, a wide examination of the published data proved that 3.1% of patients with severe epilepsy carry a pathogenic de novo mutation including STXBP1 and approximately 10.2% of early onset epileptic encephalopathy is due to an aberrant STXBP1 form codified by the mutated gene. STXBP1 mutations can be associated to a wide clinical heterogeneity. All affected individuals show developmental delay and approximately the 95% of cases have seizures and early onset epileptic encephalopathy, characterized by infantile spasms as the main consistent feature. Burst suppression pattern and hypsarrhythmia are the most frequent EEG anomalies. Other neuronal disorders include Rett syndrome and behavioral and movement disorders. Mild dysmorphic features have been detected in a small number of cases. No genotype–phenotype correlation has been reported. Management of STXBP1 encephalopathy requires a multidisciplinary approach, including epilepsy control and neurological rehabilitation. About 25% of patients are refractory to standard therapy. A single or combined antiepileptic drugs may be required. Several studies described vigabatrin, valproic acid, levetiracetam, topiramate, clobazam, and oxcarbazepine as effective in seizure control. Lamotrigine, zonisamide, and phenobarbital are also commonly used. To date, it remains unclear which therapy is the most effective. Severe morbidity and high mortality are inevitable consequences in some of these patients.

Keywords

STXBP1 - syntaxin - genetics - encephalopathy - epilepsy

^* The authors have equally contributed to this article.

Publication History

Received: 24 February 2021

Accepted: 25 February 2021

Article published online:
13 April 2021

• References

• 1 Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can J Neurol Sci 1999; 26 (04) 263-270
• 2 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: first descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes. Am J Med Genet A 2018; 176 (03) 515-550
• 3 Barbagallo M, Ruggieri M, Incorpora G. et al. Infantile spasms in the setting of Sturge-Weber syndrome. Childs Nerv Syst 2009; 25 (01) 111-118
• 4 Ruggieri M, Praticò AD, Serra A. et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
• 5 Butler KM, da Silva C, Alexander JJ, Hegde M, Escayg A. Diagnostic yield from 339 epilepsy patients screened on a clinical gene panel. Pediatr Neurol 2017; 77: 61-66
• 6 Møller RS, Larsen LH, Johannesen KM. et al. Gene panel testing in epileptic encephalopathies and familial epilepsies. Mol Syndromol 2016; 7 (04) 210-219
• 7 Mercimek-Mahmutoglu S, Patel J, Cordeiro D. et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia 2015; 56 (05) 707-716
• 8 Pavone P, Briuglia S, Falsaperla R. et al. Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13. Am J Med Genet A 2014; 164A [phone]
• 9 Scheffer IE, Berkovic S, Capovilla G. et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
• 10 Pavone P, Falsaperla R, Ruggieri M, Praticò AD, Pavone L. West syndrome treatment: new roads for an old syndrome. Front Neurol 2013; 4: 113
• 11 Helbig I, Tayoun AA. Understanding genotypes and phenotypes in epileptic encephalopathies. Mol Syndromol 2016; 7 (04) 172-181
• 12 Saitsu H, Kato M, Mizuguchi T. et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 2008; 40 (06) 782-788
• 13 Stamberger H, Nikanorova M, Willemsen MH. et al. STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy. Neurology 2016; 86 (10) 954-962
• 14 Liu S, Wang L, Cai XT, Zhou H, Yu D, Wang Z. Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: a case report and literature review. Medicine (Baltimore) 2018; 97 (18) e0663
• 15 Saitsu H, Hoshino H, Kato M. et al. Paternal mosaicism of an STXBP1 mutation in OS. Clin Genet 2011; 80 (05) 484-488
• 16 Shimojima K, Okamoto N, Goel H, Ondo Y, Yamamoto T. Familial 9q33q34 microduplication in siblings with developmental disorders and macrocephaly. Eur J Med Genet 2017; 60 (12) 650-654
• 17 Lammertse HCA, van Berkel AA, Iacomino M. et al. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission. Brain 2020; 143 (02) 441-451
• 18 Swanson DA, Steel JM, Valle D. Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. Genomics 1998; 48 (03) 373-376
• 19 Han GA, Malintan NT, Collins BM, Meunier FA, Sugita S. Munc18-1 as a key regulator of neurosecretion. J Neurochem 2010; 115 (01) 1-10
• 20 Guiberson NGL, Pineda A, Abramov D. et al. Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones. Nat Commun 2018; 9 (01) 3986
• 21 Südhof TC. The molecular machinery of neurotransmitter release (Nobel lecture). Angew Chem Int Ed Engl 2014; 53 (47) 12696-12717
• 22 Jahn R, Scheller RH. SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol 2006; 7 (09) 631-643
• 23 Ranieri C, Di Tommaso S, Loconte DC. et al. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS). Neurogenetics 2018; 19 (02) 77-91
• 24 Caltabiano R, Magro G, Polizzi A. et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst 2017; 33 (06) 933-940
• 25 Wang S, Li Y, Gong J. et al. Munc18 and Munc13 serve as a functional template to orchestrate neuronal SNARE complex assembly. Nat Commun 2019; 10 (01) 69
• 26 Rizo J. Mechanism of neurotransmitter release coming into focus. Protein Sci 2018; 27 (08) 1364-1391
• 27 Patzke C, Han Y, Covy J. et al. Analysis of conditional heterozygous STXBP1 mutations in human neurons. J Clin Invest 2015; 125 (09) 3560-3571
• 28 Saitsu H, Kato M, Matsumoto N. Haploinsufficiency of STXBP1 and Ohtahara syndrome. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV. eds. Jasper's Basic Mechanisms of the Epilepsies [Internet]. 4th ed.. Bethesda, MD: National Center for Biotechnology Information (US); 2012
• 29 Praticò AD, Falsaperla R, Ruggieri M, Corsello G, Pavone P. Prognostic challenges of SCN1A genetic mutations: report on two children with mild features. J Pediatr Neurol 2016; 14: 82-88
• 30 Donovan LE, Higginbotham L, Dammer EB. et al. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin Appl 2012; 6 (3-4): 201-211
• 31 Pavone P, Praticò AD, Ruggieri M. et al. Acquired peripheral neuropathy: a report on 20 children. Int J Immunopathol Pharmacol 2012; 25 (02) 513-517
• 32 Pavone P, Rizzo R, Conti I. et al. Primary headaches in children: clinical findings on the association with other conditions. Int J Immunopathol Pharmacol 2012; 25 (04) 1083-1091
• 33 Ruggieri M, Praticò AD, Scuderi A, Sorge G, Polizzi A. The multiple faces of artwork diagnoses. Lancet Neurol 2017; 16 (06) 417-418
• 34 Khaikin Y, Mercimek-Mahmutoglu S. STXBP1 Encephalopathy with epilepsy. In: Adam MP, Ardinger HH, Pagon RA. et al., eds. GeneReviews®. [Internet] Seattle, WA: University of Washington, Seattle; 2016: 1993-2020
• 35 Pavone P, Praticò AD, Gentile G. et al. A neurocutaneous phenotype with paired hypo- and hyperpigmented macules, microcephaly and stunted growth as prominent features. Eur J Med Genet 2016; 59 (05) 283-289
• 36 Ruggieri M, Polizzi A, Marceca GP, Catanzaro S, Praticò AD, Di Rocco C. Introduction to phacomatoses (neurocutaneous disorders) in childhood. Childs Nerv Syst 2020; 36 (10) 2229-2268
• 37 Li T, Cheng M, Wang J. et al. De novo mutations of STXBP1 in Chinese children with early onset epileptic encephalopathy. Genes Brain Behav 2018; 17 (08) e12492
• 38 Milh M, Villeneuve N, Chouchane M. et al. Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations. Epilepsia 2011; 52 (10) 1828-1834
• 39 Di Meglio C, Lesca G, Villeneuve N. et al. Epileptic patients with de novo STXBP1 mutations: key clinical features based on 24 cases. Epilepsia 2015; 56 (12) 1931-1940
• 40 Pratico AD, Longo L, Mansueto S. et al. Off-label use of drugs and adverse drug reactions in pediatric units: a prospective, multicenter study. Curr Drug Saf 2018; 13 (03) 200-207
• 41 Otsuka M, Oguni H, Liang JS. et al. STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome--result of Japanese cohort study. Epilepsia 2010; 51 (12) 2449-2452
• 42 Kodera H, Kato M, Nord AS. et al. Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy. Epilepsia 2013; 54 (07) 1262-1269
• 43 Allen NM, Conroy J, Shahwan A. et al. Unexplained early onset epileptic encephalopathy: exome screening and phenotype expansion. Epilepsia 2016; 57 (01) e12-e17
• 44 Liu J, Tong L, Song S. et al. Novel and de novo mutations in pediatric refractory epilepsy. Mol Brain 2018; 11 (01) 48
• 45 Pavone P, Praticò AD, Falsaperla R. et al. Congenital generalized hypertrichosis: the skin as a clue to complex malformation syndromes. Ital J Pediatr 2015; 41: 55
• 46 Pavone P, Falsaperla R, Ruggieri M. et al. Clinical course of N-methyl-d-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment. J Pediatr Neurol 2017; 15: 84-89
• 47 Salafia S, Praticò AD, Pizzo E, Greco F, Di Bella D. Hemiconvulsion-hemiplegia-epilepsy syndrome. Magnetic resonance findings in a 3-year-old boy. Neurol Neurochir Pol 2013; 47 (06) 584-589
• 48 Orock A, Logan S, Deak F. Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome. Mol Cell Neurosci 2018; 88: 33-42
• 49 Boutry-Kryza N, Labalme A, Ville D. et al. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. Eur J Med Genet 2015; 58 (02) 51-58
• 50 Deprez L, Weckhuysen S, Holmgren P. et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology 2010; 75 (13) 1159-1165
• 51 Saitsu H, Kato M, Okada I. et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. Epilepsia 2010; 51 (12) 2397-2405
• 52 Michaud JL, Lachance M, Hamdan FF. et al. The genetic landscape of infantile spasms. Hum Mol Genet 2014; 23 (18) 4846-4858
• 53 Allen AS, Berkovic SF, Cossette P. et al; Epi4K Consortium, Epilepsy Phenome/Genome Project. De novo mutations in epileptic encephalopathies. Nature 2013; 501 (7466): 217-221
• 54 Zhou P, He N, Zhang JW. et al. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies. Genes Brain Behav 2018; 17 (08) e12456
• 55 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Rediagnosing one of Smith's patients (John McCann) with “neuromas tumours” (1849). Neurol Sci 2017; 38 (03) 493-499
• 56 Pavone V, Signorelli SS, Praticò AD. et al. Total hemi-overgrowth in pigmentary mosaicism of the (hypomelanosis of) ito type: eight case reports. Medicine (Baltimore) 2016; 95 (10) e2705
• 57 Falsaperla R, Perciavalle V, Pavone P. et al. Unilateral eye blinking arising from the ictal ipsilateral occipital area. Clin EEG Neurosci 2016; 47 (03) 243-246
• 58 Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: Beyond SCN1A. Epilepsia 2017; 58 (11) 1807-1816
• 59 Carvill GL, Weckhuysen S, McMahon JM. et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 2014; 82 (14) 1245-1253
• 60 Álvarez Bravo G, Yusta Izquierdo A. The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment. Seizure 2018; 60: 68-70
• 61 Murillo E. [Characteristics of people with the STXBP1 syndrome in Spain: implications for diagnosis]. An Pediatr (Barc) 2020; 92 (02) 71-78 (English Ed)
• 62 Carvill GL, Heavin SB, Yendle SC. et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 2013; 45 (07) 825-830
• 63 Asadi-Pooya AA. Lennox-Gastaut syndrome: a comprehensive review. Neurol Sci 2018; 39 (03) 403-414
• 64 Mastrangelo M. Lennox-Gastaut Syndrome: a state of the art review. Neuropediatrics 2017; 48 (03) 143-151
• 65 Beal JC, Cherian K, Moshe SL, Solomon L, Moshe MD. Early-onset epileptic encephalopathies: Ohtahara syndrome and early myoclonic encephalopathy. Pediatr Neurol 2012; 47 (05) 317-323
• 66 Aravindhan A, Shah K, Pak J, Veerapandiyan A. Early-onset epileptic encephalopathy with myoclonic seizures related to 9q33.3-q34.11 deletion involving STXBP1 and SPTAN1 genes. Epileptic Disord 2018; 20 (03) 214-218
• 67 Olson HE, Tambunan D, LaCoursiere C. et al. Mutations in epilepsy and intellectual disability genes in patients with features of Rett syndrome. Am J Med Genet A 2015; 167A [phone]
• 68 Romaniello R, Saettini F, Panzeri E, Arrigoni F, Bassi MT, Borgatti R. A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype. Neuroreport 2015; 26 (05) 254-257
• 69 Lopes F, Barbosa M, Ameur A. et al. Identification of novel genetic causes of Rett syndrome-like phenotypes. J Med Genet 2016; 53 (03) 190-199
• 70 Schönewolf-Greulich B, Bisgaard AM, Møller RS. et al. Clinician's guide to genes associated with Rett-like phenotypes-investigation of a Danish cohort and review of the literature. Clin Genet 2019; 95 (02) 221-230
• 71 Yuge K, Iwama K, Yonee C. et al. A novel STXBP1 mutation causes typical Rett syndrome in a Japanese girl. Brain Dev 2018; 40 (06) 493-497
• 72 Cogliati F, Giorgini V, Masciadri M. et al. Pathogenic variants in STXBP1 and in genes for GABAa receptor subunities cause atypical Rett/Rett-like phenotypes. Int J Mol Sci 2019; 20 (15) 3621
• 73 Vidal S, Brandi N, Pacheco P. et al; Rett Working Group. The most recurrent monogenic disorders that overlap with the phenotype of Rett syndrome. Eur J Paediatr Neurol 2019; 23 (04) 609-620
• 74 Campbell IM, Yatsenko SA, Hixson P. et al. Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A. Genet Med 2012; 14 (10) 868-876
• 75 Weckhuysen S, Holmgren P, Hendrickx R. et al. Reduction of seizure frequency after epilepsy surgery in a patient with STXBP1 encephalopathy and clinical description of six novel mutation carriers. Epilepsia 2013; 54 (05) e74-e80
• 76 Wang T, Guo H, Xiong B. et al. De novo genic mutations among a Chinese autism spectrum disorder cohort. Nat Commun 2016; 7: 13316
• 77 Rauch A, Wieczorek D, Graf E. et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012; 380 (9854): 1674-1682
• 78 Kim YO, Korff CM, Villaluz MM. et al. Head stereotypies in STXBP1 encephalopathy. Dev Med Child Neurol 2013; 55 (08) 769-772
• 79 Guacci A, Chetta M, Rizzo F. et al. Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. Seizure 2016; 34: 26-28
• 80 Keogh MJ, Daud D, Pyle A. et al. A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism. Neurogenetics 2015; 16 (01) 65-67
• 81 Gburek-Augustat J, Beck-Woedl S, Tzschach A, Bauer P, Schoening M, Riess A. Epilepsy is not a mandatory feature of STXBP1 associated ataxia-tremor-retardation syndrome. Eur J Paediatr Neurol 2016; 20 (04) 661-665
• 82 Pavone P, Praticò AD, Pavone V. et al. Ataxia in children: early recognition and clinical evaluation. Ital J Pediatr 2017; 43 (01) 6
• 83 Falsaperla R, Praticò AD, Ruggieri M. et al. Congenital muscular dystrophy: from muscle to brain. Ital J Pediatr 2016; 42 (01) 78
• 84 Takezawa Y, Kikuchi A, Haginoya K. et al. Genomic analysis identifies masqueraders of full-term cerebral palsy. Ann Clin Transl Neurol 2018; 5 (05) 538-551
• 85 Kwong AK, Ho AC, Fung CW, Wong VC. Analysis of mutations in 7 genes associated with neuronal excitability and synaptic transmission in a cohort of children with non-syndromic infantile epileptic encephalopathy. PLoS One 2015; 10 (05) e0126446
• 86 Yamamoto T, Shimojima K, Yano T. et al. Loss-of-function mutations of STXBP1 in patients with epileptic encephalopathy. Brain Dev 2016; 38 (03) 280-284
• 87 Nambot S, Masurel A, El Chehadeh S. et al. 9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping. Eur J Hum Genet 2016; 24 (06) 830-837
• 88 Dilena R, Striano P, Traverso M. et al. Dramatic effect of levetiracetam in early-onset epileptic encephalopathy due to STXBP1 mutation. Brain Dev 2016; 38 (01) 128-131
• 89 Mignot C, Moutard ML, Trouillard O. et al. STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients. Epilepsia 2011; 52 (10) 1820-1827
• 90 Matsumoto H, Zaha K, Nakamura Y, Hayashi S, Inazawa J, Nonoyama S. Chromosome 9q33q34 microdeletion with early infantile epileptic encephalopathy, severe dystonia, abnormal eye movements, and nephroureteral malformations. Pediatr Neurol 2014; 51 (01) 170-175
• 91 Nicita F, Ulgiati F, Bernardini L. et al. Early myoclonic encephalopathy in 9q33-q34 deletion encompassing STXBP1 and SPTAN1. Ann Hum Genet 2015; 79 (03) 209-217
• 92 Ehret JK, Engels H, Cremer K. et al. Microdeletions in 9q33.3-q34.11 in five patients with intellectual disability, microcephaly, and seizures of incomplete penetrance: is STXBP1 not the only causative gene?. Mol Cytogenet 2015; 8: 72
• 93 Rezazadeh A, Uddin M, Snead III OC. et al. STXBP1 encephalopathy is associated with awake bruxism. Epilepsy Behav 2019; 92: 121-124
• 94 Gawlik-Kuklinska K, Iliszko M, Wozniak A. et al. A girl with duplication 9q34 syndrome. Am J Med Genet A 2007; 143A (17) 2019-2023
• 95 Ko A, Youn SE, Kim SH. et al. Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy. Epilepsy Res 2018; 141: 48-55
• 96 Uddin M, Woodbury-Smith M, Chan A. et al. Germline and somatic mutations in STXBP1 with diverse neurodevelopmental phenotypes. Neurol Genet 2017; 3 (06) e199
• 97 Arafat A, Jing P, Ma Y. et al. unexplained early infantile epileptic encephalopathy in Han Chinese children: next-generation sequencing and phenotype enriching. Sci Rep 2017; 7: 46227
• 98 Ruggieri M, Milone P, Pavone P. et al. Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients. Am J Med Genet A 2012; 158A (11) 2870-2880
• 99 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor”. Am J Med Genet A 2003; 120A [phone]
• 100 Pavone P, Praticò AD, Vitaliti G. et al. Hydranencephaly: cerebral spinal fluid instead of cerebral mantles. Ital J Pediatr 2014; 40: 79
• 101 Ruggieri M, Praticò AD, Serra A. et al. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital 2016; 36 (05) 345-367
• 102 Vincent A, Jacobson L, Plested P. et al. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita. Ann N Y Acad Sci 1998; 841: 482-496
• 103 Polizzi A, Pavone P, Ciancio E, La Rosa C, Sorge G, Ruggieri M. Hypertrichosis cubiti (hairy elbow syndrome): a clue to a malformation syndrome. J Pediatr Endocrinol Metab 2005; 18 (10) 1019-1025
• 104 Polizzi A, Pavone P, Parano E, Incorpora G, Ruggieri M. Lack of progression of brain atrophy in Aicardi-Goutières syndrome. Pediatr Neurol 2001; 24 (04) 300-302
• 105 Polizzi A, Coghill S, McShane MA, Squier W. Acute ataxia complicating Langherans cell histiocytosis. Arch Dis Child 2002; 86 (02) 130-131
• 106 Stamberger H, Weckhuysen S, De Jonghe P. STXBP1 as a therapeutic target for epileptic encephalopathy. Expert Opin Ther Targets 2017; 21 (11) 1027-1036
• 107 Praticò AD, Pavone P, Scuderi MG. et al. Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report. Cases J 2009; 2: 7394
• 108 Pratico AD, Ruggieri M, Falsaperla R, Pavone P. A probable topiramate-induced limbs paraesthesia and rigid fingers flexion. Curr Drug Saf 2018; 13 (02) 131-136
• 109 Falsaperla R, D'Angelo G, Praticò AD. et al. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav 2020; 112: 107361
• 110 Na JH, Shin S, Yang D. et al. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy. Brain Dev 2020; 42 (06) 438-448
• 111 Incorpora G, Pavone P, Castellano-Chiodo D, Praticò AD, Ruggieri M, Pavone L. Gelastic seizures due to hypothalamic hamartoma: rapid resolution after endoscopic tumor disconnection. Neurocase 2013; 19 (05) 458-461